The equitable challenges to quality use of modulators for cystic fibrosis in AustraliaMEDICAL JOURNAL OF AUSTRALIAIF8.52024-11-180OA
Providing Australian children and adolescents with equitable access to new and emerging therapies through clinical trials: a call to actionMEDICAL JOURNAL OF AUSTRALIAIF8.52023-12-191OAAI
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patientFRONTIERS IN MOLECULAR BIOSCIENCESIF42023-06-011OAAI
Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and ResearchJOURNAL OF PERSONALIZED MEDICINEIF32023-05-213OAAI
Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect气道和肠道类器官的分子动力学和热异常揭示了R352Q-CFTR电导缺陷AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGYIF5.32022-07-018OAAI
Significant functional differences in differentiated Conditionally Reprogrammed (CRC)- and Feeder-free Dual SMAD inhibited-expanded human nasal epithelial cellsJOURNAL OF CYSTIC FIBROSISIF62021-03-0123OAAI
Henoch-Schonlein Purpura With Posterior Reversible Encephalopathy SyndromePEDIATRIC NEUROLOGYIF2.12012-01-0117PREAI